However, as cathepsin K, GPNMB is expressed in TSC1/2/MTOR altered renal tumors (including eosinophilic solid and cystic renal cell carcinoma, and PEComa) [49,50]. Here, CTSK is linked to neoplasm with perivascular epithelioid cell differentiation.